CSTL FY 2021 Earnings — Castle Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CSTLCastle Biosciences, Inc.

$805M

FY 2021 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$94M+50.2% YoY

Gross Profit

$78M83.2% margin

Operating Income

-$40M-42.6% margin

Net Income

-$31M-33.3% margin

EPS (Diluted)

$-1.24

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$22M

Stock-Based Comp.

$22M

Balance Sheet

Total Assets

$463M

Total Liabilities

$51M

Stockholders' Equity

$412M

Cash & Equivalents

$330M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$94M	$63M	+50.2%
Gross Profit	$78M	$53M	+47.8%
Operating Income	-$40M	-$7M	-512.6%
Net Income	-$31M	-$10M	-204.3%